(Q35550841)

8 August 2017

title

Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls (English)

1 reference

8 August 2017

Young-Min SA

1

1 reference

8 August 2017

Beeton C

2

1 reference

8 August 2017

Laughton R

3

1 reference

8 August 2017

Plumpton T

4

1 reference

8 August 2017

Bartram S

5

1 reference

8 August 2017

Murphy G

6

1 reference

8 August 2017

Black C

7

1 reference

8 August 2017

Cawston TE

8

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Annals of the Rheumatic Diseases

8 August 2017

published in

1 reference

8 August 2017

volume

60

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

846-851

1 reference

Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts

8 August 2017

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753839

Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1.

12 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753839

Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture

12 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753839

Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis

12 July 2018

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization

1 reference

12 December 2020

Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenase

1 reference

12 December 2020

Decreased collagenase expression in cultured systemic sclerosis fibroblasts

1 reference

12 December 2020

Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts

1 reference

12 December 2020

Excess matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP-1 synthesis

1 reference

12 December 2020

Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis

1 reference

12 December 2020

Development of an enzyme-linked immunosorbent assay to measure total TIMP-1 (free TIMP-1 and TIMP-1 in combination with matrix-metalloproteinases) and measurement of TIMP 1 and CRP in serum

1 reference

12 December 2020

Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis

1 reference

12 December 2020

Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis

1 reference

12 December 2020

Identifiers

PMC publication ID

1753839

1 reference

8 August 2017

1 reference